Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $71.14 USD
Change Today -0.37 / -0.52%
Volume 3.0M
BAX On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 8:04 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Ludwig N. Hantson Ph.D.

Corporate Vice President and President of BioScience, Baxter International Inc.
AgeTotal Calculated CompensationThis person is connected to 19 board members in 2 different organizations across 7 different industries.

See Board Relationships
51$4,486,897
As of Fiscal Year 2014

Background*

Mr. Ludwig N. Hantson, Ph.D., has been the President of Synovis Life Technologies Inc. since February 14, 2012. Mr. Hantson serves as the President of Baxter BioScience Inc. He has been a Corporate Vice President for Baxter International Inc. since May 3, 2010 and has been its President of BioScience since October 2010. Mr. Hantson served as President of International at Baxter Healthcare Pty. Ltd., since May 2010. He oversaw all international operations for Baxter as ...

Read Full Background

Corporate Headquarters*

One Baxter Parkway
Deerfield, Illinois 60015

United States

Phone: 224-948-2000
Fax: --

Board Members Memberships*

Director
2012-Present
President and Director

Education*

PhD
Katholieke Universiteit Leuven
Doctorate
Universite catholique de Louvain

Other Affiliations*

Annual Compensation*

Salary$833,846
Total Annual Compensation$833,846

Stock Options*

Restricted Stock Awards$972,610
All Other Compensation$118,315
Exercised Options18,030
Exercised Options Value$621,314
Exercisable Options183,082
Exercisable Options Value$2,699,050
Unexercisable Options212,016
Unexercisable Options Value$1,148,339
Total Value of Options$4,468,703
Total Number of Options413,128

Total Compensation*

Total Annual Cash Compensation$2,323,011
Total Short Term Compensation$833,846
Other Long Term Compensation$1,090,925
Total Calculated Compensation$4,486,897
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BAX:US $71.14 USD -0.37

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Kevin A. Lobo Chairman, Chief Executive Officer and President
Stryker Corporation
$1.1M
Thomas J. Falk Executive Chairman, Chief Executive Officer and Member of Executive Committee
Kimberly-Clark Corporation
$1.3M
Heather Bresch Chief Executive Officer, Executive Director and Member of Science & Technology Committee
Mylan N.V.
$1.1M
Christophe Weber Chief Executive Officer, President and Representative Director
Takeda Pharmaceutical Company Limited
--
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
¥170.0M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BAXTER INTERNATIONAL INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.